Seeking Alpha

Hologic (HOLX) agrees to acquire Gen-Probe (GPRO) for ~$3.7B in cash, in the pairing of two...

Hologic (HOLX) agrees to acquire Gen-Probe (GPRO) for ~$3.7B in cash, in the pairing of two smidcap healthcare diagnostics companies. GPRO investors will receive $82.75/share, ~20% above its April 27 closing price. GPRO’s molecular diagnostic products include tests for chlamydia and gonorrhea, as well as human papillomavirus. GPRO +19.3%, HOLX +4.8% premarket.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs